Back to funds

Vestal Point Capital, LP

Updated 6 days ago

Managed by Vestal Point Capital, Lp • Latest filing Q3 2026

Portfolio value
$3.9B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$2.9B
Q1 2026$3.6B
Q2 2026$4.3B
Q3 2026$3.9B

Top holdings

63 positions as of Q3 2026

View filing
A

Abivax SA

Value
$392.1M
Shares
3.96M
% Port
10.13%
N

Neurocrine Biosciences Inc

Value
$354.6M
Shares
2.50M
% Port
9.16%
B

BioMarin Pharmaceutical Inc

Value
$331.5M
Shares
5.53M
% Port
8.56%
A

Arrowhead Pharmaceuticals Inc

Value
$315.1M
Shares
4.82M
% Port
8.14%
I

Insmed Inc

Value
$311M
Shares
2.73M
% Port
8.04%
U

United Therapeutics Corp

Value
$257.4M
Shares
475.0K
% Port
6.65%
A

Ascendis Pharma A/S

Value
$168.6M
Shares
740.0K
% Port
4.36%
N

Nurix Therapeutics Inc

Value
$166.6M
Shares
7.03M
% Port
4.30%
T

Tarsus Pharmaceuticals Inc

Value
$159.9M
Shares
2.03M
% Port
4.13%
E

Enliven Therapeutics Inc

Value
$147.8M
Shares
3.23M
% Port
3.82%
I

Disc Medicine Inc

Value
$107M
Shares
1.64M
% Port
2.77%
B

Bicara Therapeutics Inc

Value
$102.8M
Shares
5.53M
% Port
2.66%
D

Dyne Therapeutics Inc

Value
$99.9M
Shares
6.20M
% Port
2.58%
I

Immatics NV

Value
$98.3M
Shares
11.20M
% Port
2.54%
T

Taysha Gene Therapies Inc

Value
$87.9M
Shares
18.05M
% Port
2.27%
M

Monte Rosa Therapeutics Inc

Value
$85.1M
Shares
7.13M
% Port
2.20%
G

Globus Medical Inc

Value
$68.5M
Shares
915.0K
% Port
1.77%
C

Crescent Biopharma Inc

Value
$43.8M
Shares
3.00M
% Port
1.13%
Z

Zimmer Biomet Holdings Inc

Value
$42.2M
Shares
475.0K
% Port
1.09%
T

Travere Therapeutics Inc

Value
$35.3M
Shares
600.0K
% Port
0.91%

Explore